Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Indian Journal of Public Health|September 25, 2024
Health-care Professionals' Perception toward Medical Device Postmarket Surveillance Practices: A Cross-sectional Study in IndiaShatrunajay Shukla, Bikash Ranjan Meher, Archana Mishra, et al.
Indian Journal of Pediatrics|September 20, 2016
Risk of Intussusception with Rotavirus VaccineVivekanandan Kalaiselvan, Prasad Thota, Vipin Kumar, et al.
Indian Journal of Pharmacology|July 18, 2022
Materiovigilance Programme of India: Current status and way forwardP K Saifuddin, Moksh Tandon, Vivekanandan Kalaiselvan, et al.
Indian Journal of Pharmacology|December 4, 2018
Cefixime-associated acute generalized exanthematous pustulosis: Rare cases in IndiaVipin Kumar, Vivekanandan Kalaiselvan, A Pramod Kumar, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|February 5, 2022
Acute intraocular toxicity caused by perfluorocarbon liquids: safety control systems of medical devicesGirish K Srivastava, Vivekanandan Kalaiselvan, Cristina Andrés-Iglesias, et al.
Bulletin of the World Health Organization|March 6, 2020
Implementation of adverse event reporting for medical devices, IndiaShatrunajay Shukla, Madhur Gupta, Sabitri Pandit, et al.
Seizure|July 18, 2021
Severe cutaneous adverse reactions in Asians: Trends observed in culprit anti-seizure medicines using VigiBase®Shatrunajay Shukla, Shruti Rastogi, Sayed Aliul Hasan Abdi, et al.
Therapeutic Innovation & Regulatory Science|January 28, 2026
Indian Pharmacopoeia Reference Standards: A Key Tool to Regulate the Quality of PharmaceuticalsArvind Kumar Sharma, Shruti Rastogi, Priyanka Nagar, et al.
Expert Review of Medical Devices|January 19, 2025
A retrospective study of reported adverse events associated with cardiac stents in Indian populationSandeep Mewada, Shatrunajay Shukla, Maneesh Soni, et al.
Toxicology and Applied Pharmacology|March 31, 2020
Towards a comprehensive safety understanding of granulocyte-colony stimulating factor biosimilars in treating chemotherapy associated febrile neutropenia: Trends from decades of dataShruti Rastogi, Shatrunajay Shukla, Arvind Kumar Sharma, et al.
Pageof 4